Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer

BACKGROUND: Adjuvant chemotherapy has been shown to improve survival rates of postoperative patients with non-small cell lung cancer (NSCLC). Biomarkers could help select an appropriate chemotherapy for NSCLC patients or predict the efficacy of chemotherapy. The objective of this study was to explor...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Shi, Shun-Chang, Jiao, Li, Chen, Jie, Li, Ya-Li, Lv, Ling-Xiong, Wang
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988758/
https://www.ncbi.nlm.nih.gov/pubmed/21067592
http://dx.doi.org/10.1186/1471-2407-10-621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988758/
https://www.ncbi.nlm.nih.gov/pubmed/21067592
http://dx.doi.org/10.1186/1471-2407-10-621

Ejemplares similares